Skip to main content
. 2021 May 25;13(11):2587. doi: 10.3390/cancers13112587

Figure 1.

Figure 1

Survival after sunitinb use in patients with GIST. (A) Kaplan–Meier plot of the progression-free survival (PFS) for 109 patients with advanced gastrointestinal stromal tumor (GIST) treated with sunitinib. (B) Kaplan-Meier plot of the overall survival (OS) for 109 patients with advanced gastrointestinal stromal tumor (GIST) treated with sunitinib.